You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ipsilateral Breast Tumour Recurrence

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Tumor, Breast Trial in Cleveland (Radiation Therapy)

Not yet recruiting
  • Breast Cancer
  • Tumor, Breast
  • Radiation Therapy
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Nov 13, 2023

Invasive Breast Cancer, Ipsilateral Recurrence, Sentinel Lymph Node Biopsy Trial in France (Sentinel LN in breast cancer

Terminated
  • Invasive Breast Cancer
  • +2 more
  • Sentinel LN in breast cancer recurrence
  • Bordeaux, France
  • +8 more
Apr 19, 2022

Mastectomy Trial in Seoul (reSLNB arm)

Recruiting
  • Mastectomy
  • reSLNB arm
  • Seoul, Korea, Republic of
    Gangnam Severance Hospital, Yonsei University College of Medicin
Jul 26, 2021

Local Recurrence Following Breast Conserving Surgery and

Active, not recruiting
  • Breast Cancer
    • Calgary, Alberta, Canada
    • +26 more
    Sep 19, 2022

    Radiation OmisSion in PAtients With CLinically Node Negative

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      May 10, 2023

      Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

      Not yet recruiting
      • Breast Cancer, Early Breast Cancer
      • (no location specified)
      Jul 11, 2023

      HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

      Recruiting
      • HER2-positive Breast Cancer
      • +3 more
      • Pertuzumab and tratuzumab fixed dose combination
      • Trastuzumab emtansine
      • Auchenflower, Australia
      • +84 more
      Jan 16, 2023

      Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

      Not yet recruiting
      • Breast Cancer, Early Breast Cancer
      • (no location specified)
      Mar 7, 2023

      Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

      Recruiting
      • Breast Cancer Recurrent
      • Palbociclib 125mg
      • Standard endocrine therapy
      • Graz, Austria
      • +52 more
      Nov 15, 2022

      Triple-Negative Breast Tumor Trial in France (Biopsy, Biopsy (optional), Biopsy (metastatic))

      Active, not recruiting
      • Triple-Negative Breast Neoplasm
      • Biopsy
      • +2 more
      • Clermont-Ferrand, France
      • +9 more
      Mar 14, 2022

      Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in

      Recruiting
      • DCIS
        • Victoria, British Columbia, Canada
        • +9 more
        Jan 31, 2023

        Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

        Recruiting
        • Breast Cancer
        • Whole breast irradiation +/- tumor bed boost
        • Seoul, Korea, Republic of
          Samsung Medical Center
        May 30, 2023

        Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)

        Active, not recruiting
        • Breast Cancer
        • DCIS
        • APBI: 30 Gy
        • APBI: 27.5 Gy
        • Barrie, Ontario, Canada
        • +9 more
        Apr 4, 2022

        Spatial Location of Breast Cancer Local Recurrence After

        Active, not recruiting
        • Breast Cancer
        • Mastectomy
        • Maastricht, Limburg, Netherlands
          Maastro
        Nov 7, 2023

        ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant

        Recruiting
        • ER+ Breast Cancer
        • HER2-negative Breast Cancer
        • Palbociclib 125Mg Tab
        • +5 more
        • Christchurch, United Kingdom
        • +3 more
        May 19, 2022

        Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

        Recruiting
        • Breast Cancer
        • Gilbert, Arizona
        • +165 more
        Jan 17, 2023

        Stage I Breast Cancer Trial in United States (Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane),

        Recruiting
        • Stage I Breast Cancer
        • Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
        • Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
        • Birmingham, Alabama
        • +512 more
        Feb 1, 2023

        Breast Cancer Trial in Hospitalet de Llobregat (Intraoperative Radiotherapy (IORT), Breast conservative surgery, External Beam

        Recruiting
        • Breast Cancer
        • Intraoperative Radiotherapy (IORT)
        • +2 more
        • Hospitalet de Llobregat, Barcelona, Spain
          Evelyn Martínez
        Aug 11, 2022

        Breast Tumors, Tumor Recurrence, Local Trial in Beijing (Accelerated Partial Breast Irradiation)

        Recruiting
        • Breast Neoplasms
        • Neoplasm Recurrence, Local
        • Accelerated Partial Breast Irradiation
        • Beijing, Beijing, China
          National Cancer Center/Cancer Hospital, Chinese Academy of Medic
        Jan 6, 2022

        Breast Cancer, Recurrent Trial in Meldola (Partial breast re-irradiation)

        Not yet recruiting
        • Breast Cancer
        • Recurrent
        • Partial breast re-irradiation
        • Meldola, Forlì Cesena, Italy
          UO Radioterapia, IRST IRCCS
        Mar 6, 2023

        High-Risk Cancer, Locally Advanced Breast Cancer Trial in London (Neoadjuvant radiotherapy)

        Recruiting
        • High-Risk Cancer
        • Locally Advanced Breast Cancer
        • Neoadjuvant radiotherapy
        • London, Ontario, Canada
          London Regional Cancer Program
        Aug 11, 2021

        Breast Cancer Trial in Shanghai (adjuvant hypofractionated intensity-modulated proton radiotherapy)

        Recruiting
        • Breast Cancer
        • adjuvant hypofractionated intensity-modulated proton radiotherapy
        • Shanghai, Shanghai, China
          Shanghai Proton and Heavy Ion center
        Jan 11, 2023

        Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

        Recruiting
        • Triple Negative Breast Cancer
        • HER2-positive Breast Cancer
        • proton plus carbon ion radiotherapy
        • Shanghai, China
          Shanghai Proton and Heavy Ion center
        Jan 11, 2023

        Breast Cancer Trial in Cleveland (intracavitary balloon brachytherapy, intraoperative radiation therapy)

        Completed
        Has Results
        • Breast Cancer
        • intracavitary balloon brachytherapy
        • intraoperative radiation therapy
        • Cleveland, Ohio
        • +2 more
        Aug 6, 2020

        Breast Cancer Trial in Italy, Portugal, Spain (Irradiation)

        Completed
        • Breast Cancer
        • Irradiation
        • Perugia, Italy
        • +49 more
        Mar 20, 2022